ArticleJournal of clinical immunology2013

SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin.

Kuo-Chih Tseng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.